Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dolby Family Ventures invests in early-stage (primarily pre-clinical, Phase 1, and some Phase 2) life science and precision neuroscience companies, backing diverse modalities and platforms targeting neurodegeneration, cognition, and disease-modifying therapeutics. Portfolio companies such as Vandria are entering Phase 1 for lead programs like VNA-318, targeting mitophagy for CNS and neurodegenerative indications.[1][2][4]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dolby Family Ventures.